RANGWALA RESHMA (EVP & Chief Medical Officer) sold 8.2% of their position (5.07K shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $47.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2026ACC: 0001825322-26-000003
Officer· EVP & Chief Medical Officer
Since Apr 2022
-5.07K
Net shares
Net seller
$47.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.07K
Price / share
$9.41
Trade value
$47.67K
% of position
8.2%
3/2/2026
61.80K→56.74K
Total
Net shares
−5.07K
Net value
-$47.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −5.07K | $9.41 | $47.67K | 8.2% | 61.80K | 56.74K |
| Total | −5.07K | -$47.67K | ||||||
Derivative Transactions0
No derivative transactions reported